STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses ...

Keratoconus patients often go through multiple stages of treatment. Procedures such as Holcomb C3-R® or Intacs® are designed to stabilize and reshape the cornea. Even with those interventions, some ...

He emphasized the ongoing strength of the company’s EVO ICL technology in the growing myopia correction market and announced ...

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses ...

Dr. Bishop performed three EVO ICL surgeries on Monday morning. The procedure is for anyone 21 to 45 years old who meets a certain range of nearsightedness or astigmatism. It's a minimally ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision ...

This transaction follows strategic investment by ICL Planet and more than two years of close collaboration between ICL and Lavie Bio, focused on developing innovative bio-stimulant solutions for ...

The implantable lens maker posted a net loss of $54.2 million, or $1.10 per share, compared to a loss of $3.3 million, or $0.07 per share, in the year-ago quarter. Adjusted earnings per share came in ...

He emphasized the ongoing strength of the company’s EVO ICL technology in the growing myopia correction market and announced new leadership structures, including the promotion of Warren Faust to ...